Since it was established as an NLRP3 inhibitor, it has been used as a pharmacological instrument to unravel the pathogenic functions of the NLRP3 inflammasome in several disease models, including T2DM, ATS, and many others [46]. The gene discussed is NLRP3; the disease is Andersen-Tawil syndrome.